Zurn Elkay Reports Strong Q1 2026 Results with Double-Digit Sales & EPS Growth, Boosts Share Buyback & Credit Facility
Summary
Zurn Elkay Water Solutions delivered strong Q1 2026 financial results, marked by double-digit growth in sales and earnings, alongside a significant share repurchase and an expanded credit facility.
Key Events
-
Strong Q1 2026 Financial Performance
Net sales increased by 11.4% to $433.0 million, net income grew 35.1% to $58.9 million, and diluted EPS rose 34.6% to $0.35 compared to the prior year quarter. Income from operations increased by 29.5% to $82.1 million, with operating margin improving by 270 basis points.
-
Significant Share Repurchase Activity
The company repurchased 1,047,291 shares of common stock for $50.0 million during the first quarter of 2026, at an average price of $47.71 per share. Approximately $432.1 million of repurchase authority remains under the existing program.
-
Enhanced Credit Facility and Liquidity
The revolving credit facility commitment was increased from $200.0 million to $550.0 million, and its maturity date was extended to February 19, 2031, significantly boosting the company's liquidity and financial flexibility. The company's Total Net Leverage Ratio was 0.57 to 1.00, well below the covenant maximum of 4.00 to 1.00.
-
Director Adopts 10b5-1 Trading Plan
Director Timothy J. Jahnke adopted a new Rule 10b5-1 trading plan on February 13, 2026, to sell 60,000 shares, with the first trade scheduled no earlier than May 15, 2026. This is a pre-planned disposition.
Analysis
Zurn Elkay Water Solutions reported robust first-quarter 2026 financial results, demonstrating strong operational performance. The company achieved significant year-over-year growth in net sales, net income, and diluted EPS, driven by favorable sales growth and productivity initiatives. Concurrently, the company continued its share repurchase program, buying back a substantial amount of stock, and significantly expanded its revolving credit facility, enhancing its liquidity and financial flexibility. A director's adoption of a 10b5-1 trading plan for future share sales is a routine, pre-scheduled disclosure and does not reflect immediate market sentiment.
At the time of this filing, ZWS was trading at $48.68 on NYSE in the Technology sector, with a market capitalization of approximately $8B. The 52-week trading range was $29.39 to $53.17. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.